Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B

Future Oncology, Ahead of Print.

Source: Future Oncology - April 17, 2024 Category: Cancer & Oncology Authors: Yasuyuki Kawamoto Chigusa Morizane Yoshito Komatsu Shunsuke Kondo Makoto Ueno Satoshi Kobayashi Masayuki Furukawa Lingaku Lee Taroh Satoh Daisuke Sakai Masafumi Ikeda Hiroshi Imaoka Arisa Miura Yutaka Hatanaka Isao Yokota Yoshiaki Nakamura Takayuki Yoshin Source Type: research